What makes Relistor (methylnaltrexone) expensive?
Relistor’s high price mostly comes down to it being a specialty, low-volume product that targets a narrow group of patients and requires specific clinical use rather than broad, everyday prescribing.
Because the drug is used only in certain opioid-related constipation settings (not general constipation), demand is smaller than for mass-market therapies, which pushes up the effective cost per patient. Specialty distribution and pharmacy handling for drugs like this also tend to add to the final price.
Is Relistor still protected by patents or exclusivity?
When a brand-name drug still has active patent protection and/or regulatory exclusivity, there is typically no generic or biosimilar competition to pressure the price down. Brand pricing often stays high until those protections expire and cheaper alternatives enter the market.
You can check the patent and exclusivity situation for Relistor on DrugPatentWatch.com: https://www.drugpatentwatch.com/ . (Use the site’s Relistor/Methylnaltrexone entry to see the relevant filings and expected timelines.)
How do specialty drug markups and insurance rules affect the “out-of-pocket” cost?
Even when insurers cover Relistor, the patient’s cost can be high because many specialty drugs come with:
- Prior authorization requirements
- Step therapy rules
- High copays/coinsurance when the drug is not covered as “preferred”
- Coverage limits tied to diagnosis and previous treatment attempts
Those payer mechanics can make the drug feel “expensive” at the point of purchase even if negotiated insurance pricing exists.
Is there cheaper competition (generics or alternatives) that could lower the price?
If there are other peripherally acting mu-opioid receptor antagonists (PAMORAs) available for the same constipation indications, patients may be able to switch to a lower-cost option depending on formulary rules. Whether that reduces cost depends on:
- What your insurer lists as preferred
- Whether a different agent is considered medically appropriate for your situation
- Prior authorization outcomes
If no formulary alternative is approved, Relistor may remain the covered option, which keeps costs high.
Why do some patients end up paying more than others?
Two patients can have very different bills for the same drug because of:
- Different insurance plans and negotiated rates
- Different pharmacy channels (specialty pharmacy vs. other dispensing)
- Different dosing regimens and treatment duration
- Whether treatment qualifies for full coverage under the insurer’s criteria
So “Relistor is expensive” can reflect both the branded drug economics and how payers structure coverage.
Source